Martin Ssejjoba
Scientist B – Project Leader MRC/UVRI & LSHTM Uganda Research Unit, Uganda Email: ssejjobakiri@gmail.com
VALIDATE Role: Network Affiliate
Research Keywords: Tuberculosis Immunology and Clinical Trials, TB Postmortem Research, B Cells and Antibodies
Biography: I hold a Master of Science in Immunology and Clinical Microbiology from Makerere University in Uganda. My master’s research focused on investigating antibody responses to Mycobacterial glycans and glycolipids as potential indicators of protection against Mycobacterium tuberculosis infection in BCG-vaccinated children. Since then, I have worked as a laboratory technologist and senior laboratory technologist in various research studies and clinical trials. My work has included involvement in a multi-country epidemiological study assessing interferon-gamma release assay (IGRA) positivity and building capacity for Tuberculosis (TB) vaccine efficacy studies in high TB burden populations. Additionally, I contributed to a multicenter, phase III, double-blind, randomized, active-controlled study evaluating the efficacy and safety of VPM1002 compared to BCG in preventing Mycobacterium tuberculosis infection in newborns. Currently, I serve as a Scientist B and Project Leader on a Tuberculosis Post-Mortem Study in Uganda, employing a discovery-driven approach to investigate resident tissue cell subsets and their functions, comparing findings between active TB disease and latent TB infection (LTBI) subjects.
Related Websites:
Key Publications:
|
